TELA Bio Announces Addition of Betty Jo Rocchio to Board of Directors and the Departure of Director Lisa Colleran

Core Insights - TELA Bio, Inc. has appointed Dr. Betty Jo Rocchio to its Board of Directors, while Lisa Colleran has stepped down after five years of service [1][3][4] Group 1: Appointment of Dr. Rocchio - Dr. Rocchio is a nationally recognized healthcare leader with extensive experience in clinical excellence and supply-chain transformation [2][5] - Currently, she serves as Executive Vice President and Chief Nurse Executive at Advocate Health, overseeing over 42,000 nurses [2][4] - Dr. Rocchio expressed her commitment to aligning clinical excellence with financial sustainability at TELA Bio [3][4] Group 2: Departure of Lisa Colleran - Lisa Colleran has resigned from the Board after five years, contributing significantly to TELA Bio's strategy and commercial growth [3][4] - Her leadership experience includes roles as CEO of IC Surgical and former CEO of LifeCell Corporation [3][4] Group 3: Company Overview - TELA Bio focuses on innovative soft-tissue reconstruction solutions that prioritize the preservation of the patient's anatomy [7] - The company aims to provide advanced, cost-effective solutions that enhance patient outcomes while minimizing the use of permanent synthetic materials [7]